Abstract
Obesity is a chronic and highly prevalent disease worldwide. Most obese individuals develop sleep-disordered breathing (SDB) manifested by recurrent upper airway obstruction during sleep (OSA) and obesity hypoventilation, defined as daytime hypercapnia in obese individuals in the absence of other underlying causes. There is no effective pharmacotherapy for SDB. Leptin, an adipose-produced…